F.D.A. Panel to Reassess Hormone Therapy Warnings

Health
By Roni Caryn Rabin from NYT Health https://ift.tt/ItJWDZo
via IFTTT your-feed-science, Hormones, Women and Girls, Menopause, Drugs (Pharmaceuticals), Breast Cancer, Heart, Stroke, Dementia, Conflicts of Interest, Estrogen, Women's Health Initiative, Vagina, Clinical Trials Dr. Marty Makary, the agency’s commissioner, has said too many women avoid menopause treatments because the risks have been overstated.

Comments

Popular posts from this blog

U.S. Quietly Drafts Plan to End Program That Saved Millions From AIDS

The Jarring Contradiction at the Heart of Kennedy’s Agenda